Skip to main content
. 2019 Sep 12;14(9):e0222408. doi: 10.1371/journal.pone.0222408

Table 3. Methodological quality of the included studies.

First Author, Year Random sequence generation Allocation concealment Blinding of participants and personnel Blinding of outcome assessment Incomplete outcome data Selective reporting Other source of bias
Sanders 2008[16] Computer-generated Pharmacy Low risk High risk Low risk Low risk Unclear
Slobbe 2010[17] Computer-generated Pharmacy Low risk Low risk Low risk Low risk Unclear
Broom 2012[18] Computer-generated Central distribution High risk High risk Low risk Low risk Unclear
Yang 2013[19] Unclear Unclear High risk High risk Low risk Unclear Unclear
Sun 2014[20] Computer-generated Unclear High risk High risk Low risk Low risk Unclear
Worth 2014[21] Unclear Unclear High risk High risk Low risk Unclear Unclear
Schoot 2015[22] Computer-generated Central distribution Low risk Low risk Low risk Low risk Unclear
Souweine 2015[23] Unclear Unclear Low risk High risk Low risk Low risk Unclear
Salonen 2017[24] Computer-generated Unclear Low risk Low risk Low risk Low risk Unclear